Haoyan Guo, PhD, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China, Email:
J Prev Alzheimers Dis. 2022;9(2):306-314. doi: 10.14283/jpad.2021.69.
Updated information on the burden of Alzheimer's disease and other forms of dementia are of great importance for evidence-based health care planning. However, such an estimate has been lacking in Chinese populations at both national and provincial levels.
To estimate the temporal trends and the attributable burdens of selected risk factors of Alzheimer's disease and other forms of dementia in China.
DESIGN, SETTING, AND PARTICIPANTS: This is an observational description of the Global Burden of Diseases Study 2019 (GBD 2019). Data on incidence, mortality, prevalence, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) of Alzheimer's disease and other forms of dementia were derived from the GBD 2019 study at both national and provincial levels in China.
Six indicators were used: incidence, mortality, prevalence, DALYs, YLLs, and YLDs. Absolute numbers in detail by age, sex, region, and age-standardized rates (with 95% uncertainty intervals) were calculated.
There were notable increasing trends in the number of deaths (247·9%), incidence (264·8%), prevalence (296·5%), DALYs (228·1%), YLDs (308·7%) and YLLs (201·7%) from 1990 to 2019, respectively. The corresponding age-standardized rates increased by 6·2%, 19·3%, 33·6%, 10·7%, 33·4% and 3·1%. Smoking, high body mass index, high fasting plasma glucose levels, and metabolic risks were the four leading risk factors. Higher burden was observed among females versus males and in the more developed regions.
The disease burden in China were increasing substantially. Regional differences of the disease burden are accompanied by discrepancies of economic level and geographical location, as well as different levels of exposure to risk factors. Targeted prevention and control strategies are urgently needed to reduce the disease burden.
更新阿尔茨海默病和其他形式痴呆症负担的相关信息对循证医疗规划具有重要意义。然而,中国在国家和省级层面上都缺乏这方面的相关估计数据。
评估中国阿尔茨海默病和其他形式痴呆症的特定危险因素的时间趋势和归因负担。
设计、设置和参与者:这是 2019 年全球疾病负担研究(GBD 2019)的观察性描述。中国国家和省级层面的阿尔茨海默病和其他形式痴呆症的发病率、死亡率、患病率、残疾调整生命年(DALYs)、残疾生存年(YLDs)和生命损失年(YLLs)数据来源于 GBD 2019 研究。
使用了六个指标:发病率、死亡率、患病率、DALYs、YLLs 和 YLDs。按年龄、性别、地区和年龄标准化率(95%置信区间)详细计算了绝对数字。
1990 年至 2019 年,死亡人数(247.9%)、发病率(264.8%)、患病率(296.5%)、DALYs(228.1%)、YLDs(308.7%)和 YLLs(201.7%)的数量呈显著上升趋势。相应的年龄标准化率分别增加了 6.2%、19.3%、33.6%、10.7%、33.4%和 3.1%。吸烟、高身体质量指数、高空腹血糖水平和代谢风险是四个主要危险因素。女性的负担高于男性,发达地区的负担更高。
中国的疾病负担正在大幅增加。疾病负担的地区差异伴随着经济水平和地理位置的差异,以及接触危险因素的水平不同。迫切需要采取有针对性的预防和控制策略来减轻疾病负担。